Exagen

XGN · NASDAQ

$7.41−$0.02 (−0.27%)TodayMarket closed ·
Prev close $7.43

Who owns XGN

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 49.1% of XGN’s shares.

  • Chernett (Jorey)10.0%
  • Tullis Health Investors7.2%
  • H.I.G. Capital, LLC7.0%
  • NMSIC Co-Investment Fund, L.P5.7%
  • Next 6 largest institutions19.2%
  • All other shareholders50.9%
Top institutional holders of XGN
HolderShares% of shares
Chernett (Jorey)2.41M9.99%
Tullis Health Investors1.75M7.23%
H.I.G. Capital, LLC1.70M7.02%
NMSIC Co-Investment Fund, L.P1.37M5.67%
Parian Ultreia LP1.29M5.35%
Hunt Holdings, L.P829.28K3.43%
Wexford Capital LP792.86K3.28%
Vanguard Capital Management, LLC612.83K2.54%
Fourworld Capital Management LLC596.53K2.47%
Silvercrest Asset Management Group LLC514.76K2.13%

Largest mutual fund holders

Top mutual fund holders of XGN
HolderShares% of shares
Vanguard Total Stock Market Index Fund414.85K1.72%
First Eagle Small Cap Opportunity Fund261.22K1.08%
Vanguard Extended Market Index Fund190.49K0.79%
Florida State Board Administration Fund137.22K0.57%
Fidelity Extended Market Index Fund66.54K0.28%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $148.78K (1 trade) of XGN on the open market, with no buys.

Latest XGN insider transactions
InsiderTypeSharesValue
Black Jeffrey G.Award1.57K$4.74K
Black Jeffrey G.Sale20.61K$148.78K
Robertson Bruce CAward37.50K—
Kim PaulAward37.50K—
Robertson Bruce CAward37.50K—
Stokes FrankAward37.50K—
McKhann ChasAward37.50K—
KAHN SCOTT DAward37.50K—

Short interest

Settled Sep 30, 2026

Shares short
704.63K
Days to cover
2.46
% of shares outstanding
2.92%
Average daily volume
286.37K
Change since last report
−12.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.